{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ixekizumab",
          "type": "Drug",
          "label": "Ixekizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_neratinib",
          "type": "Drug",
          "label": "Neratinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tazarotene",
          "type": "Drug",
          "label": "Tazarotene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_gp_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_th17",
          "type": "Target",
          "label": "Th17 cells",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_il17",
          "type": "Target",
          "label": "IL-17",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_tnf",
          "type": "Target",
          "label": "TNF",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_inflammation",
          "type": "Pathway",
          "label": "Inflammatory Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_immune_response",
          "type": "Pathway",
          "label": "Immune Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph1",
          "type": "Phenotype",
          "label": "Skin Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph2",
          "type": "Phenotype",
          "label": "Pustular Lesions",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "OffTarget_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "RiskPathway_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "AdversePhenotype_Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_corticosteroids",
          "type": "Target",
          "label": "OffTarget_Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_corticosteroids",
          "type": "Pathway",
          "label": "RiskPathway_Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_corticosteroids",
          "type": "Phenotype",
          "label": "AdversePhenotype_Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "OffTarget_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "RiskPathway_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "AdversePhenotype_Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Ixekizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Brodalumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Neratinib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Tazarotene",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_acitretin",
          "target": "n_target_th17",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用机制"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "常用于抑制炎症"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_pathway_inflammation",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响免疫通路"
        },
        {
          "source": "drug_infliximab",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_etanercept",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_ixekizumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_neratinib",
          "target": "n_pathway_inflammation",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "假设影响炎症"
        },
        {
          "source": "drug_apremilast",
          "target": "n_pathway_immune_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "影响免疫通路"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_ph1",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知治疗效果"
        },
        {
          "source": "n_target_th17",
          "target": "n_pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_target_il17",
          "target": "n_pathway_immune_response",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_target_tnf",
          "target": "n_pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_pathway_inflammation",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与皮肤炎症相关"
        },
        {
          "source": "n_pathway_inflammation",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与脓疱损伤相关"
        },
        {
          "source": "n_pathway_immune_response",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫通路相关结局"
        },
        {
          "source": "n_pathway_immune_response",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫通路相关结局"
        },
        {
          "source": "drug_acitretin",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_infliximab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_etanercept",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_ixekizumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_neratinib",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_apremilast",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在旁路作用可能影响其他靶点"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，可能抵消净获益"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_ot_corticosteroids",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在旁路作用可能影响其他靶点"
        },
        {
          "source": "n_ot_corticosteroids",
          "target": "n_rp_corticosteroids",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响风险通路"
        },
        {
          "source": "n_rp_corticosteroids",
          "target": "n_adv_corticosteroids",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_corticosteroids",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，可能抵消净获益"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在旁路作用可能影响其他靶点"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，可能抵消净获益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.76,
          "components": {
            "mechanism_fit": 0.9,
            "class_prior": 0.7,
            "pk_pd_feasibility": 0.8,
            "indication_plausibility": 0.8,
            "safety_risk": 0.25,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Acitretin adverse effects",
                "pro": [
                  "drug_acitretin"
                ],
                "con": [
                  "n_adv_acitretin"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "映射至Th17细胞的已知作用机制"
            ],
            "safety_risk": [
              "存在潜在的不良表型声明"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Acitretin的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.72,
          "components": {
            "mechanism_fit": 0.85,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.75,
            "safety_risk": 0.25,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.9,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Corticosteroids adverse effects",
                "pro": [
                  "drug_corticosteroids"
                ],
                "con": [
                  "n_adv_corticosteroids"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "抑制TNF机制在治疗炎症方面的有效性"
            ],
            "safety_risk": [
              "存在潜在的不良表型声明"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Corticosteroids的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.71,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.75,
            "safety_risk": 0.3,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Methotrexate adverse effects",
                "pro": [
                  "drug_methotrexate"
                ],
                "con": [
                  "n_adv_methotrexate"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "调节免疫通路以治疗炎症"
            ],
            "safety_risk": [
              "存在潜在的不良表型声明"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Methotrexate的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.68,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.75,
            "indication_plausibility": 0.7,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.78,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Infliximab adverse effects",
                "pro": [
                  "drug_infliximab"
                ],
                "con": []
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "直接作用于TNF以减少炎症反应"
            ],
            "safety_risk": [
              "少量不良表型声明"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Infliximab的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.65,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.65,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.7,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "作为TNF抑制剂发挥作用"
            ],
            "safety_risk": [
              "需确认对患者的长期影响"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Adalimumab的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.64,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.65,
            "indication_plausibility": 0.6,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.65,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "抑制IL-17以治疗皮肤炎症"
            ],
            "safety_risk": [
              "缺乏足够的长期安全性数据"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Secukinumab的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.63,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.5,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.65,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "作用于TNF抑制，减轻炎症"
            ],
            "safety_risk": [
              "需确认可能的副作用"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Etanercept的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.62,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.5,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.55,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "抑制IL-17以减轻皮肤炎症"
            ],
            "safety_risk": [
              "缺乏充分的安全性验证"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Ixekizumab的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.6,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.55,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "抑制IL-17的潜在有效性"
            ],
            "safety_risk": [
              "缺乏充分的安全性验证"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需进一步分析Brodalumab的安全性与长期效果"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.55,
            "indication_plausibility": 0.45,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "对炎症的影响尚不明确"
            ],
            "safety_risk": [
              "缺乏安全性和疗效的强有力数据"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "需进一步分析Neratinib的适用性"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.55,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.45,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.45,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "作用机制尚不明确"
            ],
            "safety_risk": [
              "缺乏强有力的支持证据"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "需进一步分析Apremilast的适用性"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.45,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.45,
            "indication_plausibility": 0.4,
            "safety_risk": 0.35,
            "graph_bonus": 0.15,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.45,
            "contradiction_weight": 0.4,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "作用机制尚不明确"
            ],
            "safety_risk": [
              "缺乏足够证据支持其安全性"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "需进一步分析Tazarotene的适用性"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Acitretin adverse effects",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_acitretin",
            "via": [
              "n_target_th17"
            ],
            "to": "n_gp_psoriasis",
            "success_criteria": "形成至少1条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "讨论Acitretin的安全性风险与临床获益的权衡",
          "确认Acitretin对其他靶点的潜在影响"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Corticosteroids adverse effects",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_corticosteroids",
            "via": [
              "n_target_tnf"
            ],
            "to": "n_gp_psoriasis",
            "success_criteria": "形成至少1条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "探讨Corticosteroids的安全性并权衡其临床效益"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Methotrexate adverse effects",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_methotrexate",
            "via": [
              "n_pathway_inflammation"
            ],
            "to": "n_gp_psoriasis",
            "success_criteria": "形成至少1条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "确认Methotrexate对患者长期使用的安全性质疑"
        ]
      }
    ],
    "seed_request": {
      "should_regenerate": false,
      "reason": "现有候选的机制结构连通性不足，且存在多个不良反应声明的冲突需进一步明确，未达种子再生标准。",
      "n": 4
    }
  }
}